<DOC>
	<DOCNO>NCT00219115</DOCNO>
	<brief_summary>To evaluate blood pressure lower effect combination aliskiren 300 mg HCTZ 25 mg obese patient essential hypertension inadequately treat HCTZ 25 mg , compare irbesartan amlodipine HCTZ HCTZ alone .</brief_summary>
	<brief_title>A Clinical Study Compare Combination Aliskiren+ HCTZ Irbesartan+ HCTZ Amlodipine+ HCTZ HCTZ Alone Obese Hypertensive Not Responsive HCTZ 25 mg</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Irbesartan</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>Inclusion Criteria Patients essential hypertension Patients body mass index â‰¥ 30 kg/m2 Exclusion Criteria Severe hypertension History evidence secondary form hypertension History Hypertensive encephalopathy cerebrovascular accident . Other protocoldefined inclusion exclusion criterion also apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Hypertension , aliskiren , blood pressure , irbesartan , amlodipine , hydrochlorothiazide</keyword>
</DOC>